InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Orpheus Uranium Limited (ASX:ORP)

ALERT: Price-sensitive ASX Announcement for ORP
Current share price for ORP : $0.097 -0.018 (-15.65%)+
Announcement
Release
14 Aug 2026 8:20AM
Price at Release
$0.115
Full Release
download
Summary
Adavale Resources Limited has finalized a Sale Agreement with Orpheus Uranium Limited for its Marree Embayment Uranium Portfolio, marking a strategic pivot from non-core assets to its core focus on gold-copper projects. The sale involves 7 exploration licences, a $650,000 cash transaction, and 5,000,000 shares in Orpheus, keeping Adavale engaged in the uranium sector through a 1.25% stake. This transaction aligns with Adavale's focus on enhancing its Parkes Project in NSW, while Orpheus' share price growth reflects strong market confidence in their uranium exploration potentials. The agreement's finalization requires regulatory approvals and the assignment of Native Title Mining Agreements.
Key Points
  • Adavale Resources executed a Sale Agreement with Orpheus Uranium Limited for the Marree Embayment Uranium Portfolio.
  • The agreement includes the sale of 7 exploration licences for $650,000 cash and 5,000,000 Orpheus shares.
  • Adavale retains a 1.25% shareholding in Orpheus, maintaining exposure to uranium assets.
  • The transaction shifts Adavale's focus to its gold-copper assets at the Parkes Project in NSW.
  • Orpheus' share price nearly doubled since the binding agreement, indicating positive market engagement.
  • Adavale is committed to releasing an updated Mineral Resource for the Parkes Project this quarter.
  • The transaction includes conditions precedent, such as Native Title Mining Agreements assignment and regulatory approvals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.